Resolution pharmacology and the treatment of infectious diseases
Vivian Vasconcelos Costa1*#, Filipe Resende1*, Eliza Mathias Melo2, Mauro Martins Teixeira2#
1Centro de Pesquisa e Desenvolvimento de Fármacos, Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
2 Centro de Pesquisa e Desenvolvimento de Fármacos, Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
*Both contributed equally to this work.
Author for correspondence:
#Mauro Martins Teixeira - Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais. Av. Antônio Carlos, 6627 - Pampulha - CEP 31270-901 - Belo Horizonte, MG, Brasil. Phone #55 31 34096883.
E-mail: mmtex.ufmg@gmail.com / mmtex@icb.ufmg.br
#Vivian Vasconcelos Costa – Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais. Av. Antônio Carlos, 6627 - Pampulha - CEP 31270-901 - Belo Horizonte, MG, Brasil. Phone #55 31 34093082.
E-mail: vivianvcosta@gmail.com/ vivianvcosta@ufmg.br
Word count: 7418
Acknowledgements: The authors thank L’Oréal-UNESCO-ABC ‘Para Mulheres na Ciência’ prize granted to VVC, and the PhD scholarship provided by CAPES to F.R., under project process 88881.507175/2020-01.
Financial support: This work received financial support from the National Institute of Science and Technology in Dengue and Host-microorganism Interaction (INCT dengue), a program funded by The Brazilian National Science Council (CNPq, Brazil process 465425/2014-3) and Minas Gerais Foundation for Science (FAPEMIG, Brazil process 25036/2014-3) and from Rede de Pesquisa em Imunobiológicos e Biofármacos para terapias avançadas e inovadoras (ImunoBioFar), provided by FAPEMIG under process RED-00202-22” 29568-1 and FAPEMIG process APQ-02281-18. This study was also financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil), process 88881.507175/2020-01.
Conflict of interest statement: No competing interests declared.